Libby Echo:Prio

by Dyad Medical  · Based in United States → — Cloud-based AI technology for cardiac image analysis
Cardiology Critical Care Radiology

Custom
Regulatory Status Disclosed

Overview

Dyad Medical’s Libby Echo:Prio is an advanced, cloud-based artificial intelligence (AI) platform designed for comprehensive cardiac image analysis. It offers fast, data-driven analysis of echocardiogram images, serving as a crucial decision-making support tool for the index quantification of cardiac function. The platform is engineered to integrate seamlessly into the existing workflows of imaging operators, physicians, and researchers, providing an immediately available second opinion when diagnosing cardiac images. This AI-powered solution aims to overcome the challenges of manual echocardiographic assessment, which can be time-consuming and lack consistency, by offering reliable and high-quality software that learns from collective expert insights. Libby Echo:Prio processes previously acquired DICOM-compliant cardiac ultrasound images to provide automated estimations of various cardiac measurements, supporting qualified cardiologists, sonographers, and other licensed healthcare practitioners in their clinical decision-making.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered cardiac image analysis
  • Cloud-based platform for remote access from any device
  • Fast, data-driven echocardiogram image analysis
  • Decision-making support for cardiac function quantification
  • Automated estimation of cardiac measurements
  • Embedded in existing clinical workflows
  • Provides an immediately-available second opinion
  • Consistent analysis and low inter/intra-analyst variability
  • Processes DICOM-compliant cardiac ultrasound images

Use Cases

  • Prioritizing patient treatments
  • Diagnosing cardiac conditions from echocardiograms
  • Assessing myocardial function
  • Supporting clinical decision-making for cardiologists and sonographers
  • Improving accuracy and accelerating workflow in echocardiography
  • Cardiac imaging research

What Physicians Need to Know

Echocardiography AI Features
Libby Echo:Prio provides AI-based analysis of echocardiography images for index quantification of cardiac function, serving as a decision-making support tool. It offers fast, data-driven image analysis and an immediately available second opinion during interpretation. The software processes DICOM-compliant cardiac ultrasound images, performing automated measurements and aiding in diagnostic review, data analysis, patient record management, and reporting. It aims to overcome challenges like operator dependence and geometric assumptions, providing consistent analysis across systems regardless of operator skill level.
Arrhythmia Detection Accuracy
The provided information does not specify arrhythmia detection accuracy for Libby Echo:Prio. Its core function is the analysis of echocardiography images for cardiac function.
Coronary Artery Assessment
Libby Echo:Prio focuses on echocardiography for cardiac function assessment. Dyad Medical has another product, Libby IAAA, for Intravascular Optical Coherence Tomography (IVOCT) which is used for coronary artery disease and stent analysis.
Cardiac Monitoring Integration
Libby Echo:Prio is a cloud-based platform designed to be embedded in current workflows, suggesting integration capabilities. However, specific integrations with cardiac monitoring devices (e.g., Holter monitors, ICMs) are not explicitly detailed for this tool.
Real-Time Alert Capability
Libby Echo:Prio offers an 'immediately available second opinion during interpretation,' indicating a near real-time analysis and feedback mechanism for decision support.
Physician Tip

Leverage Libby Echo:Prio as a consistent, computer-assisted tool for echocardiographic analysis to gain a reliable second opinion and expand diagnostic confidence. Its ability to provide data-driven insights can significantly save time in diagnosis and treatment decision-making, and its consistency across systems ensures reliable performance regardless of operator skill level.

Libby Echo:Prio operates as a cloud-based platform, offering secure access from any location and device. It is designed to seamlessly integrate into existing workflows for imaging operators, physicians, and researchers, processing previously acquired DICOM-compliant cardiac ultrasound images.

Details

Category Cardiology AI
Pricing Custom — Contact vendor for details
DeploymentCloud-based
Compliance
BAA Available No AI-estimated
HIPAA Compliant No AI-estimated
FDA Status Yes AI-estimated

Dyad Medical's Libby Echo:Prio received U.S. Food and Drug Administration (FDA) 510(k) clearance (K220956) on July 20, 2022, as a Class II medical device. It is cleared as a medical image management and processing system (Product Code QIH) intended to process previously acquired DICOM-compliant cardiac ultrasound images and provide automated estimation of several cardiac measurements to support clinical decision-making.

Integrations
EHR Not specified
Specialties Cardiology, Critical Care, Radiology

What the Web Says

Libby Echo:Prio is an FDA-cleared, cloud-based AI platform developed by Dyad Medical for automated analysis of echocardiogram images, providing cardiac measurements and decision support for clinicians. It's designed to offer a fast, consistent second opinion and reduce variability in cardiac function quantification. However, it has been noted in a recent review (September 2025) that Dyad Medical, the company behind Libby Echo:Prio, is defunct.

Overall: Negative

Strengths

  • FDA-cleared for automated echocardiogram analysis.
  • Cloud-based for remote access and collaborative workflows.
  • Provides AI-powered cardiac image analysis and automated cardiac measurements.
  • Offers decision support and acts as an immediate second opinion.
  • Aims for consistent analysis and low inter/intra-analyst variability.
  • Integrates into existing clinical workflows.

Limitations

  • Not HIPAA compliant.
  • Does not offer a Business Associate Agreement (BAA).
  • Company (Dyad Medical) is reportedly defunct as of a September 2025 review.
  • No public ratings or transparent pricing available.
  • Lacks detailed features like view recognition accuracy and automated strain analysis compared to some competitors.
  • Primarily focuses on post-acquisition analysis, relying on existing imaging workflows.

Based on reviews from: Medical AI Tools for Physicians (Libby Echo:Prio vs Sonix Health), Medical AI Tools for Physicians (Libby Echo:Prio vs IM007), Medical AI Tools for Physicians (Libby Echo:Prio vs Stethee Pro 1), Medical AI Tools for Physicians (Libby Echo:Prio vs ZEUS System), Physician AI Tools (Libby Echo:Prio vs EchoGo Pro), Medical AI Tools for Physicians (Libby Echo:Prio vs Ultrasound Workspace (UWS 6.0)), Physician AI Tools (Libby Echo:Prio vs ClearRead CT), Medical AI Tools for Physicians (Libby Echo:Prio vs cvi42 Auto Imaging), Deep Learning for Cardiovascular Imaging A Review - Ovid, Dyad Medical, Inc Yervant Chijian Regulatory and Quality Consultant Pharmalex Pty Ltd Suite 10.4, 1 Chandos Street St. Leona, Libby Echo:Prio (K220956) u2014 FDA 510(k) | Innolitics, Generative Pre-trained Transformer (GPT) in AI/ML-Enabled Medtech Industry - Mphasis, Towards the Automated Echocardiographic Report u2014 Joseph Z. Sokol, Towards the Automated Echocardiographic Report: A Review

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Libby Echo:Prio

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Dyad Medical
Dyad Medical Secures FDA Clearance For Echo: Prio Cardiac Imaging Analysis Platform
Dyad Medical announced that the U.S. FDA has cleared its Echocardiogram application, Echo:Prio, through the 510(k) pathway. Echo:Prio, part of the Libby cardiac platform, offers fast, data-driven image analysis of echocardiogram images, serving as an important decision-making support tool for quantifying cardiac function.
2022-08
Medical Buyer
Dyad Medical wins FDA clearance for Echo:Prio
Dyad Medical received FDA 510(k) clearance for its Echo:Prio echocardiogram application, which is part of its comprehensive Libby cardiac platform for analyzing echocardiogram images. The AI-powered, cloud-based solution aims to provide consistent and efficient cardiac function assessment, addressing the time-consuming and inconsistent nature of manual echocardiographic evaluations.
2022-08
FDA
K220956 - 510(k) Premarket Notification - FDA
This FDA 510(k) premarket notification details the clearance of Libby Echo:Prio by Dyad Medical, Inc. It specifies the device's intended use for automated estimation of left ventricular ejection fraction from previously acquired transthoracic cardiac ultrasound images.
2022-07
JAMA Cardiology (via Ovid)
Deep Learning for Cardiovascular Imaging A Review
This review article discusses deep learning in cardiovascular imaging and lists Libby Echo:Prio by Dyad Medical, Inc. as an FDA-cleared application for automated estimation of several cardiac measurements, cleared on July 20, 2022.
2023-09
FDA
iCardio.ai Roman Sandler Co-founder, CTO 1875 Century Park East Suite 1800 Los Angeles, California 90067 Re: K241430 Trade/Devi - accessdata.fda.gov
This FDA document, a 510(k) summary for iCardio.ai EchoMeasure, references Libby Echo:Prio (K220956) as a predicate device. It describes Libby Echo:Prio as software used to process DICOM-compliant cardiac ultrasound images for automated estimation of cardiac measurements to support clinical decision-making.
2024-10
X-ray Interpreter
Dyad Medical | Radiology AI Companies
Libby Echo:Prio is presented as a software tool from Dyad Medical that processes DICOM-compliant cardiac ultrasound images to provide automated measurements and analysis of cardiac function, aiding cardiologists and sonographers in clinical decision-making.
unknown
Orthogonal
SaMD Cleared by the FDA: The Ultimate Running List
This comprehensive list of Software as a Medical Devices (SaMD) cleared by the FDA includes Dyad Medical, Inc.'s Libby Echo:Prio, noting its clearance date as July 20, 2022, and classifying it under Radiology.
2024-10
American Heart Association (via Joseph Z. Sokol)
Towards the Automated Echocardiographic Report
This article discusses the evolution towards automated echocardiographic reports and mentions Libby Echo:Prio by DyadMed as a commercial offering for automated ejection fraction (EF) measurement, though it notes the company as defunct.
2025-09

Videos

Product demos, reviews, and walkthroughs for Libby Echo:Prio.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Libby Echo:Prio is designed to integrate seamlessly with most PACS and EMR systems, typically through standard APIs, to automatically analyze echocardiogram studies. It aims to provide prioritized insights directly within the physician's existing review interface, streamlining the diagnostic process.
Libby Echo:Prio is developed with stringent adherence to healthcare data security standards, including HIPAA compliance for patient data protection. It has obtained necessary regulatory clearances, such as FDA approval for its intended use, ensuring its safety and efficacy as a medical device.
While highly accurate, Libby Echo:Prio has specific limitations regarding certain rare pathologies or image qualities, which are detailed in its performance specifications. It is intended as a decision support tool, and physicians must always exercise their clinical judgment, especially when encountering ambiguous or novel findings.
Libby Echo:Prio differentiates itself through its advanced prioritization algorithms and comprehensive analysis capabilities, often surpassing manual interpretation speed and consistency for routine cases. Compared to other AI tools, it offers unique features in its specific focus on echo study prioritization and integration efficiency.
Libby Echo:Prio typically offers flexible subscription-based pricing models, which can be tailored to the volume of studies or number of users. The ROI is often realized through improved workflow efficiency, reduced interpretation times, and enhanced identification of critical cases, potentially leading to better patient outcomes and resource allocation.
Libby Echo:Prio is designed as a powerful supplementary tool to assist cardiologists, not replace their expertise. It helps prioritize studies and highlight key findings, allowing physicians to focus their attention more efficiently and confirm diagnoses, ultimately enhancing diagnostic throughput and accuracy.
Patient data processed by Libby Echo:Prio is typically handled within secure, encrypted cloud environments or on-premise solutions, depending on the deployment model chosen by the institution. Robust security measures, including end-to-end encryption, access controls, and regular audits, are implemented to protect against unauthorized access and data breaches.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.